Quibim introduces QP-Liver for enhancing liver disease diagnosis through MRI analysis

Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through highly accurate quantification of tissue fat and iron from MRI scans. It has been given a CE and UKCA mark for the European Union and United Kingdom respectively, meaning it is cleared to be used in those markets.

Opinion | Extend the Hospital-at-Home Waiver Before It’s Too Late

Fulmer is a practicing nurse and president of a philanthropy dedicated to improving care for older adults. In November 2020, with the COVID pandemic severely

August 8, 2024

LifeLongFit project receives funding to explore the effects of mild stress on healthy aging

Dr. Maria Ermolaeva from the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena has received the coveted ERC Consolidator Grant from the

July 21, 2023

Abbott, Medtronic partner on diabetes tech

Dive Brief: Abbott and Medtronic said Wednesday they will partner to create an integrated continuous glucose monitor that works with Medtronic’s diabetes technology. Abbott will

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.